India, Jan. 16 -- During Friday's trading session, shares of a global pharmaceutical company with a strong focus on complex generics and sustainable growth, and ranked as India's third-largest pharma player, slumped around 5 percent on the stock exchanges. What led to the sharp fall? Here's a closer look.

At 11:48 a.m., shares of Cipla Limited were trading in the red at Rs. 1,400.8 on BSE, down by around 2.4 percent, compared to its previous closing price of Rs. 1,434.6, with a market cap of Rs. 1.13 lakh crores. The stock has delivered negative returns of around 3 percent in one year, and has fallen by over 6 percent in the last one month.

As per its latest regulatory disclosure, Cipla Limited informed that the US Food and Drug Adminis...